Shares

9 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Jul 25, 2024

SELL
$16.0 - $21.1 $1,824 - $2,405
-114 Reduced 0.97%
11,683 $194,000
Q1 2024

Apr 25, 2024

BUY
$20.64 - $25.45 $243,490 - $300,233
11,797 New
11,797 $252,000
Q3 2023

Oct 25, 2023

BUY
$27.56 - $35.7 $60,576 - $78,468
2,198 Added 27.17%
10,288 $286,000
Q2 2023

Jul 28, 2023

BUY
$31.53 - $39.74 $255,077 - $321,496
8,090 New
8,090 $273,000
Q4 2021

Jan 26, 2022

SELL
$37.73 - $46.74 $190,083 - $235,476
-5,038 Closed
0 $0
Q3 2021

Nov 12, 2021

SELL
$39.75 - $44.09 $12,680 - $14,064
-319 Reduced 5.95%
5,038 $211,000
Q2 2021

Aug 06, 2021

SELL
$40.83 - $45.48 $69,125 - $76,997
-1,693 Reduced 24.01%
5,357 $231,000
Q1 2021

May 11, 2021

BUY
$32.95 - $41.63 $12,619 - $15,944
383 Added 5.74%
7,050 $288,000
Q4 2020

Feb 12, 2021

BUY
$24.49 - $33.73 $163,274 - $224,877
6,667 New
6,667 $225,000

Others Institutions Holding NVST

About Envista Holdings Corp


  • Ticker NVST
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Instruments & Supplies
  • Shares Outstandng 163,391,008
  • Market Cap $3.5B
  • Description
  • Envista Holdings Corporation, together with its subsidiaries, engages in the development, sale, and marketing of dental products in the United States, China, and internationally. The company operates in two segments, Specialty Products & Technologies and Equipment & Consumables. The company's Specialty Products & Technologies segment...
More about NVST
Track This Portfolio

Track Verdence Capital Advisors LLC Portfolio

Follow Verdence Capital Advisors LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Verdence Capital Advisors LLC, based on Form 13F filings with the SEC.

News

Stay updated on Verdence Capital Advisors LLC with notifications on news.